The main findings of this study were: 1) the fragment was significantly elevated in lung cancer and IPF patients compared to healthy controls 2) the fragment was detectable in serum and 3) the assay was technically robust and specific towards a unique Cat-S degraded fragment of decorin, DCN-CS. Here, DCN is linked to idiopathic pulmonary fibrosis.